PA Medical News about mild persistent asthma; inhaled corticosteroid therapy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The ADMIT series - Issues in Inhalation Therapy. 3)Mild persistent asthma: the case for inhaled corticosteroid therapy
Primary Care Respiratory Journal, 06/11/09

Corrigan CJ et al. - Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduces exacerbations of disease, controls symptoms and reduces bronchial mucosal inflammation. Most patients can be controlled with low dosage ICS (<= 500 mcg/day beclometasone or equivalent) and there is limited benefit from further escalating dosages. There is some evidence of additional benefit of early treatment in terms of better longer term control of symptoms, but not alteration of the natural history of the disease. Withdrawal of ICS therapy results in rapid relapse of symptoms. Although some studies have suggested that intermittent therapy with ICS is not detrimental to asthma control, in the absence of any studies investigating the long term clinical, functional and pathophysiological differences between regular and intermittent therapy, the former continues to be recommended in guidelines. In patients well controlled on low/moderate dosages of ICS there is little benefit of adding any other medication and no rationale for commencing combination therapy routinely as first line controller therapy.

<< Previous
The Safety of Metoclopramide Use in the First Trimester of...

Next >>
Improved Pain Resolution in Hospitalized Patients through...

Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges
Current Medical Research and Opinion, 10/19/09 Relevance Score: 81%

Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma
Drugs & Therapy Perspectives, 10/16/09 Relevance Score: 81%

Leukotriene modifiers in the treatment of asthma in children
Therapeutic Advances in Respiratory Disease, 11/06/09 Relevance Score: 80%

Clinical effects of a Long-term Educational Program for Children with Asthma - Aironet. A 1-yr randomized controlled trial
Pediatric Allergy and Immunology, 10/19/09 Relevance Score: 80%

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma
Pediatric Research, 10/29/09 Relevance Score: 79%